Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
34.37%
Operating Margin
116.41%
Net Margin
98.93%
Efficiency Metrics
Revenue per Expense Ratio
1.00
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
116.41%
Income Tax Rate
0.00%
EPS
1.8200000000
Balance Sheet Analysis
Current Ratio
0.00
Cash Ratio
0.00
Working Capital
$-121.00M
Debt to Equity
0.39
Debt to Assets
27.75%
Equity Ratio
71.09%
Cash Flow Analysis
Operating Cash Flow Ratio
43.05%
Free Cash Flow Ratio
43.05%
CapEx to Revenue
0.00%
Dividends Paid
$28.79M
Stock Buybacks
No buybacks
Total Shareholder Returns
$28.79M
Cash Position Change
-99.99%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
174.87%
Net Income
173.38%
EPS
173.39%
Operating Income
191.68%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-13.41%
Operating Cash Flow
-65.47%
Free Cash Flow
-65.47%
Balance Sheet Health
Assets
0.85%
Debt
-4.90%
Book Value per Share
4.53%
Inventory
0.00%
Shareholder Returns
Dividends per Share
-8.41%
Shares Outstanding
0.00%
Long Term Trends
3Y Revenue/Share
3,879.89%
5Y Revenue/Share
261.14%
3Y Dividend/Share
12.04%
5Y Dividend/Share
-8.16%